Publications by authors named "Todd Berner"

Claim this Profile
R
Real-World Phosphate Binder Use among Dialysis-Dependent Patients with CKD.
Todd Berner, Christine Ferro, Gabriela Dieguez, Steve Metz, Jennifer Moore

Nephron· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook" [Mol Genet Metab. 2019 May;127(1):12-22].
Nastassja Himmelreich, Riccardo Montioli, Mariarita Bertoldi, Carla Carducci, Vincenzo Leuzzi, Todd Berner

Mol Genet Metab· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient experience with subcutaneous immunoglobulin 20%, Ig20Gly, for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials.
Lisa M Meckley, Yanyu Wu, Diane Ito, Todd Berner, Barbara McCoy

BMC Immunol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook.
Nastassja Himmelreich, Riccardo Montioli, Mariarita Bertoldi, Carla Carducci, Vincenzo Leuzzi, Todd Berner

Mol Genet Metab· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinics.
Adrian Wagg, Victor W Nitti, Con Kelleher, David Castro-Diaz, Emad Siddiqui, Todd Berner

Curr Med Res Opin· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data.
Adrian Wagg, Demitri Diles, Todd Berner

J Health Econ Outcomes Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Outcomes in Patients with Overactive Bladder within an Integrated Healthcare Delivery System Using a Treatment Patterns Analyzer.
Daniel B Ng, Melissa McCart, Christopher Klein, Chelsey Campbell, Robert Schoenhaus, Todd Berner

Am Health Drug Benefits· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Use and Cost in Individuals with Overactive Bladder.
Brandon T Suehs, Cralen Davis, Billy Franks, Thomas E Yuran, Daniel Ng, Todd Berner

J Am Geriatr Soc· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada.
Adrian Wagg, Billy Franks, Barbara Ramos, Todd Berner

Can Urol Assoc J· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in the Pharmacological Management of Nursing Home Residents with Overactive Bladder or Urinary Incontinence.
Barbara J Zarowitz, Carrie Allen, Terrence O'Shea, Eric G Tangalos, Todd Berner

J Am Geriatr Soc· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid Medication Practices Observed in Chronic Pain Patients Presenting for All-Causes to Emergency Departments: Prevalence and Impact on Health Care Outcomes.
Frank R Ernst, J Rebecca Mills, Todd Berner, John House, Christopher Herndon

J Manag Care Spec Pharm· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Burden and Nonpharmacologic Management of Nursing Facility Residents with Overactive Bladder and/or Urinary Incontinence.
Barbara J Zarowitz, Carrie Allen, Terrence O'Shea, Eric Tangalos, Todd Berner

Consult Pharm· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
Jack Barkin, Demitri Diles, Billy Franks, Todd Berner

Can J Urol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource use and costs of privately insured patients who switch, discontinue, or persist on anti-muscarinic therapy for overactive bladder.
Jasmina I Ivanova, Eleanor Hayes-Larson, Rachael A Sorg, Howard G Birnbaum, Todd Berner

J Med Econ· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HCl.
Noam Y Kirson, Alan G White, Howard G Birnbaum, Matt Schiller, Tracy Waldman, Todd Berner

J Med Econ· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of Daily Average Consumption Of Oxycodone Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With Low Back Pain.
Todd Berner, Heather Thomson, Ann Hartry, R Amy Puenpatom, Rami Ben-Joseph

P T· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
Stephen D Silberstein, Todd Berner, John Tobin, Qinfang Xiang, John C Campbell

Headache· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis